ARCHIVES

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

This article is from The Cancer Letter archive.

Vol. 05 No. 46 | November 16, 1979

Download PDF Visit The Full Archive

Related Articles

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Hawaii Epidemiology Studies Offer Opportunities For Major Impact On Cancer Incidence, Survival

January 4, 1985

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

Radiation Table Recommendations Completed

July 22, 1983

President to Propose 2 Percent Increase in NIH Budge, Slowing Funding Growth

January 15, 1999

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998